Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Associations of genetically determined lipid traits and lipid-modifying agents with the risk of diabetic retinopathy: A Mendelian randomization study.

Atherosclerosis - 1 Mar 2023

Li Ning, Zhang Xiaoyu, Zhang Meng, Wu Lijuan, Li Changwei, Pan Yuesong, Wang Wei, Ji Jianguang, Zheng Deqiang

Abstract excerpt

BACKGROUND AND AIMS: The evidence that dyslipidemia is associated with hyperglycemia calls for an investigation of whether dyslipidemia, as well as lipid-modifying agents, could affect the subsequent development of diabetic retinopathy (DR). Therefore, we aimed to address these unanswered questions by utilizing Mendelian randomization (MR) analysis. METHODS: Genetic variants were selected from the UK Biobank as...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cholesterol, HDL
Share to Cholesterol, LDL

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Diabetes Mellitus

Share to Diabetic Retinopathy

Share to Dyslipidemias

Share to Genome-Wide Association Study

Share to Mendelian Randomization Analysis

Share to Triglycerides

Source

Identifiers

PMID: 36827905
DOI: 10.1016/j.atherosclerosis.2023.02.001

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Associations of genetically determined lipid traits and lipid-modifying agents with the risk of diabetic retinopathy: A Mendelian randomization study.PMID 36827905Read ↗

Genetically Determined Plasma Lipid Levels and Risk of Diabetic Retinopathy: A Mendelian Randomization Study.Semantic proximity Read ↗

BMI and plasma lipid levels with risk of proliferative diabetic retinopathy: a univariable and multivariable Mendelian randomization studySemantic proximity Read ↗

Statins as a risk factor for diabetic retinopathy: a Mendelian randomization and cross-sectional observational studySemantic proximity Read ↗

Genetic Association between Lipid-Regulating Drug Targets and Diabetic Retinopathy: A Drug Target Mendelian Randomization StudySemantic proximity Read ↗

The Causal Relationship and Association between Biomarkers, Dietary Intake, and Diabetic Retinopathy: Insights from Mendelian Randomization and Cross-Sectional StudySemantic proximity Read ↗

Diabetic retinopathy risk in patients with unhealthy lifestyle: A Mendelian randomization studySemantic proximity Read ↗

Novel High-Resolution Lipidomes Could Serve as New Biomarkers for Diabetic Retinopathy: A Bidirectional and Mediated Mendelian Randomization Study.Semantic proximity Read ↗

Causal Roles of Lipids and Mediating Proteins in Diabetic Retinopathy: Insights from Metabolomic and Proteomic Mendelian RandomizationSemantic proximity Read ↗

Effects of genetically proxied statins on diabetic nephropathy and retinopathy: a Mendelian randomization study.Semantic proximity Read ↗

Assessment of the association between genetic factors regulating thyroid function and microvascular complications in diabetes: A two-sample Mendelian randomization study in the European populationSemantic proximity Read ↗

Potential disease biomarkers for diabetic retinopathy identified through Mendelian randomization analysisSemantic proximity Read ↗

Relationship between remnant cholesterol and the risk of diabetic microvascular complications in type 2 diabetes: An observational studySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.